Skip to content

Tenofovir: low resistance risk for new drug after six months therapy

HAART in the real world: Swiss findings

Comprehensive Geneva conference summaries

Therapeutic drug monitoring: better test for NRTIs?

AIDS dementia rate rises in Sydney, but falls in London

Nevirapine liver toxicity: US reminder issued

Understanding unsafe sex in the age of HAART

Handy medication schedule software for pharmacies

UK heterosexual HIV diagnoses overtake gay men for first time